amoxicillin + doxycycline + metronidazole + vancomycin

This is a combination of four antibiotics—amoxicillin, doxycycline, metronidazole, and vancomycin—each with distinct mechanisms of action. Amoxicillin is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis. Doxycycline is a tetracycline-class antibiotic that inhibits protein synthesis by binding to the 30S ribosomal subunit. Metronidazole acts primarily against anaerobic bacteria and protozoa by disrupting DNA structure through reduction-activated cytotoxic intermediates. Vancomycin is a glycopeptide antibiotic that inhibits cell wall biosynthesis in gram-positive bacteria by binding to D-Ala-D-Ala termini of cell wall precursor units. This specific four-drug combination does not correspond to any approved or widely used fixed-dose product but may be considered in rare or experimental settings for severe polymicrobial infections or as salvage therapy in refractory cases where broad-spectrum coverage—including both aerobic and anaerobic organisms—is required[1][4]. Each component has established use individually or in dual/triple combinations for various infections (e.g., dental infections, periodontitis, Clostridioides difficile infection), but the quadruple regimen would be highly unusual due to overlapping spectra, increased risk of adverse effects (including disruption of normal flora), drug interactions, and potential for resistance development[1][2][3][5].

Other names

amoxicillin and doxycycline and metronidazole and vancomycinamoxicillin/doxycycline/metronidazole/vancomycin combination